← Leaderboards
Michelle M Martinez
Universidad Central Del Caribe
$1,318,870
Attributed
$1,321,870
Total exposure
6
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $130.9K · FY2010–25$200K$150K$100K$50K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,321,870 · 6
By mechanism
R16$468,116 · 1
SC3$461,142 · 1
G12$386,612 · 3
R13$6,000 · 1
Top collaborators
- Ivette Suarez1 shared
Most similar at Universidad Central Del Caribe
Same institution · by research overlap
- Ivette Suarez$477,027
- Robert Hunter$4,555,263
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsMalignant Breast NeoplasmBreast Cancer CellIn VivoCancer CellChemotherapyCellsApoptosisResistanceInvadedTumor VolumeProteinsCell DeathNeoplasm MetastasisLymphatic SystemEnvironmentPathway InteractionsReishi MushroomCell SurvivalTumorMouse ModelMcf10a CellsAffectNeoplastic Cell
Grant awards (14)
Validating the mode of action of ergosterol peroxide as a selective breast cancer inhibitor$117,029
R16 · FY2025 · GM · contact PI
Validating the mode of action of ergosterol peroxide as a selective breast cancer inhibitor$117,029
R16 · FY2024 · GM · contact PI
Puerto Rico Cancer Research Meeting$6,000
R13 · FY2024 · CA · contact PI
Validating the mode of action of ergosterol peroxide as a selective breast cancer inhibitor$117,029
R16 · FY2023 · GM · contact PI
Validating the mode of action of ergosterol peroxide as a selective breast cancer inhibitor$117,029
R16 · FY2022 · GM · contact PI
Sensitization of breast cancer and cancer stem cell to systemic therapy by Reishi$92,990
SC3 · FY2019 · GM · contact PI
Sensitization of breast cancer and cancer stem cell to systemic therapy by Reishi$92,038
SC3 · FY2017 · GM · contact PI
Sensitization of breast cancer and cancer stem cell to systemic therapy by Reishi$92,038
SC3 · FY2016 · GM · contact PI
Sensitization of breast cancer and cancer stem cell to systemic therapy by Reishi$92,038
SC3 · FY2015 · GM · contact PI
Sensitization of breast cancer and cancer stem cell to systemic therapy by Reishi$92,038
SC3 · FY2014 · GM · contact PI
INVESTIGATION OF REISHI AS A NATURAL THERAPEUTIC FOR INFLAMMATORY BREAST CANCER$122,405
G12 · FY2013 · MD · contact PI
INVESTIGATION OF REISHI AS A NATURAL THERAPEUTIC FOR INFLAMMATORY BREAST CANCER$130,915
G12 · FY2012 · MD · contact PI
INVESTIGATION OF REISHI AS A NATURAL THERAPEUTIC FOR INFLAMMATORY BREAST CANCER$54,754
G12 · FY2011 · RR · contact PI
INVESTIGATION OF REISHI AS A NATURAL THERAPEUTIC FOR INFLAMMATORY BREAST CANCER$78,538
G12 · FY2010 · RR · contact PI